Tag: pathogens

LOS ANGELES, June 18, 2025 (GLOBE NEWSWIRE) -- XYZ Media, a leading media company that bridges educational pursuits with technological innovation, is thrilled to announce the next feature in its “Next Generation of Innovators” series, a digital campaign that shines a light on the extraordinary young leaders shaping the future through inventive solutions to global challenges. This series proudly features Matthew Lo, a student from Haverford School in Haverford, PA, for developing a novel AI-powered system for honeybees to aid crop pollination through sunflowers amid record-breaking honeybee population losses.

Fast Track status enables expedited regulatory review timelines and supports the development of recombinant human plasma gelsolin (rhu-pGSN), a novel immune modulator for inflammatory diseases.

Leuven, Belgium, June 12, 2025 – AstriVax Therapeutics NV, a clinical stage immunotherapy company developing novel treatments for chronic infections based on its proprietary Launch-iT technology, announced today the appointment of Dieter Weinand as Chair of the Board of Directors, effective June 12, 2025. Mr. Weinand is the former Chief Executive Officer of Bayer Pharma AG with more than 25 years of experience as a senior business leader in the pharmaceutical industry. He takes over from Dr. Jeanne Bolger, who served as Chair since 2022 and will remain on the Board as a non-executive independent director.